IRTC

iRhythm Technologies to Present at the William Blair 44th Annual Growth Stock Conference

Retrieved on: 
星期三, 五月 22, 2024
IRTC, Conference, Interest, SAN, Central Time

SAN FRANCISCO, May 22, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, announced today that the company will be participating in the upcoming William Blair 44th Annual Growth Stock Conference.

Key Points: 
  • SAN FRANCISCO, May 22, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, announced today that the company will be participating in the upcoming William Blair 44th Annual Growth Stock Conference.
  • iRhythm’s management is scheduled to present on Wednesday, June 5, at 11:20 a.m. Central Time.
  • Interested parties may access a live and archived webcast of the presentation on the “Events & Presentations” section of the company’s investor website at investors.irhythmtech.com .

IRHYTHM ALERT: Bragar Eagel & Squire, P.C. is Investigating iRhythm Technologies, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

Retrieved on: 
星期三, 五月 22, 2024
IRTC, Patient, Justice, J. P. Morgan, Heart failure, Subpoena duces tecum, FDA, Telephone, Stroke, Marketing, Growth, ECG, Atrial fibrillation, Zio, P.C, Boston Scientific, DOJ, Medical device

Our investigation concerns whether the board of directors of iRhythm have breached their fiduciary duties to the company.

Key Points: 
  • Our investigation concerns whether the board of directors of iRhythm have breached their fiduciary duties to the company.
  • The Company’s principal product is a monitoring patch that provides electrocardiogram (“ECG”) monitoring for up to 14 days, called Zio XT.
  • The Zio XT is intended for non-critical patients, as it does not provide real-time reporting.
  • As a result of these misrepresentations, the price of iRhythm common stock traded at artificially inflated prices throughout the Class Period.

iRhythm Technologies Announces First Quarter 2024 Financial Results

Retrieved on: 
星期四, 五月 2, 2024
EKG, ACC, HRS, IRTC, Traction, Growth, Patient, Heart failure, SAN, Interest, Pharmaceutical industry

SAN FRANCISCO, May 02, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today reported financial results for the three months ended March 31, 2024.

Key Points: 
  • SAN FRANCISCO, May 02, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today reported financial results for the three months ended March 31, 2024.
  • Revenue for the first quarter of 2024 was $131.9 million, up 18.4% from $111.4 million during the same period in 2023.
  • Operating expenses for the first quarter of 2024 were $125.7 million, compared to $115.2 million for the same period in 2023.
  • Adjusted operating expenses for the first quarter of 2024 were $125.7 million, compared to $109.5 million during the same period in 2023.

iRhythm Technologies to Report First Quarter 2024 Financial Results on May 2, 2024

Retrieved on: 
星期四, 四月 18, 2024
Disease, IRTC, SAN

SAN FRANCISCO, April 18, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today announced that it will release financial results for the first quarter 2024 after the close of trading on Thursday, May 2, 2024.

Key Points: 
  • SAN FRANCISCO, April 18, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today announced that it will release financial results for the first quarter 2024 after the close of trading on Thursday, May 2, 2024.
  • The company’s management team will host a corresponding conference call beginning at 1:30 p.m. PT / 4:30 p.m.
  • ET.

Investigation Alert Amylyx, Hut 8, Xponential Fitness, and iRhythm Technologies: Submit Your Information Now to Johnson Fistel, LLP

Retrieved on: 
星期一, 四月 15, 2024
Organization, LLP, Hut 8, IRTC, SAN, Cryptocurrency

The investigation targets specific officers and directors within several companies.

Key Points: 
  • The investigation targets specific officers and directors within several companies.
  • These companies include Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX), Hut 8 Corp. (NASDAQ: HUT), Xponential Fitness, Inc. (NYSE: XPOF), and iRhythm Technologies, Inc. (NASDAQ: IRTC).
  • The goal of this investigation is to ensure that the laws governing corporate behavior are being upheld, and to protect shareholder interests within these organizations.
  • Recently class action lawsuits were filed against the following Companies, seeking damages, but only for those who acquired stock during (the “Class Period”).

IRTC IMPORTANT DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages iRhythm Technologies, Inc. Investors to Secure Counsel Before Important April 8 Deadline in Securities Class Action - IRTC

Retrieved on: 
星期三, 四月 3, 2024
Titan, Zio, Growth, Plaintiff, Patient, Class, IRTC, Advertising, Court, Insurance

WHAT TO DO NEXT: To join the iRhythm class action, go to https://rosenlegal.com/submit-form/?case_id=22399 or call Phillip Kim, Esq.

Key Points: 
  • WHAT TO DO NEXT: To join the iRhythm class action, go to https://rosenlegal.com/submit-form/?case_id=22399 or call Phillip Kim, Esq.
  • WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles.
  • The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
  • 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017.

IRTC DEADLINE ALERT: ROSEN, LEADING INVESTOR COUNSEL, Encourages iRhythm Technologies, Inc. Investors With Losses in Excess of $100K to Secure Counsel Before Important April 8 Deadline in Securities Class Action - IRTC

Retrieved on: 
星期四, 三月 28, 2024
Titan, Zio, Growth, Plaintiff, Patient, Class, IRTC, Advertising, Court, Insurance

WHAT TO DO NEXT: To join the iRhythm class action, go to https://rosenlegal.com/submit-form/?case_id=22399 or call Phillip Kim, Esq.

Key Points: 
  • WHAT TO DO NEXT: To join the iRhythm class action, go to https://rosenlegal.com/submit-form/?case_id=22399 or call Phillip Kim, Esq.
  • A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
  • The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
  • 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017.

ROSEN, NATIONAL TRIAL COUNSEL, Encourages iRhythm Technologies, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - IRTC

Retrieved on: 
星期日, 三月 17, 2024
Titan, Zio, Growth, Plaintiff, Patient, Class, IRTC, Advertising, Court, Insurance

WHAT TO DO NEXT: To join the iRhythm class action, go to https://rosenlegal.com/submit-form/?case_id=22399 or call Phillip Kim, Esq.

Key Points: 
  • WHAT TO DO NEXT: To join the iRhythm class action, go to https://rosenlegal.com/submit-form/?case_id=22399 or call Phillip Kim, Esq.
  • The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
  • Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company.
  • 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017.

iRhythm Technologies, Inc. investors: Please contact the Portnoy Law Firm to recover your losses; April 8, 2024 deadline

Retrieved on: 
星期一, 四月 8, 2024
Letter, Disclosure, Justice, Lung compliance, Marketing, FDA, IRTC, Pharmaceutical industry

LOS ANGELES, April 08, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises iRhythm Technologies, Inc. (NASDAQ: IRTC) investors that a lawsuit was filed on behalf of investors that purchased iRhythm securities between January 11, 2022 and May 30, 2023, 2023, inclusive (the “Class Period”).

Key Points: 
  • LOS ANGELES, April 08, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises iRhythm Technologies, Inc. (NASDAQ: IRTC) investors that a lawsuit was filed on behalf of investors that purchased iRhythm securities between January 11, 2022 and May 30, 2023, 2023, inclusive (the “Class Period”).
  • Investors are encouraged to contact attorney Lesley F. Portnoy , by phone 310-692-8883 or email : [email protected], to discuss their legal rights, or click here to join the case via www.portnoylaw.com .
  • The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors’ options for pursuing claims to recover their losses.
  • The Portnoy Law Firm represents investors in pursuing claims caused by corporate wrongdoing.

IRTC DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages iRhythm Technologies, Inc. Investors to Secure Counsel Before Important April 8 Deadline in Securities Class Action – IRTC

Retrieved on: 
星期一, 四月 8, 2024
Titan, Zio, Growth, Patient, Class, IRTC, Advertising, Court, Insurance

WHAT TO DO NEXT: To join the iRhythm class action, go to https://rosenlegal.com/submit-form/?case_id=22399 or call Phillip Kim, Esq.

Key Points: 
  • WHAT TO DO NEXT: To join the iRhythm class action, go to https://rosenlegal.com/submit-form/?case_id=22399 or call Phillip Kim, Esq.
  • WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles.
  • The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
  • 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017.